Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer

NCT00771810 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Thrombocytopenia
Neutropenia
Lymphopenia
Anemia

Interventions

DRUG: TXA127
DRUG: TXA127
DRUG: Placebo

Sponsor

Tarix Pharmaceuticals